Applied Therapeutics stock (APLT) was down 75% early Friday on news the FDA had declined to approve its drug govorestat, ...

Power needs for artificial intelligence and cloud computing are expanding so rapidly that some data center campuses may use ...

RBC Capital analyst Gregory Pardy maintained a Buy rating on MEG Energy (MEGEF – Research Report) today and set a price target of C$33.00. The ...

Fintel reports that on November 26, 2024, RBC Capital initiated coverage of Dyne Therapeutics (NasdaqGS:DYN) with a ...

RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) on November 25 and set a price target of $50.00. The ...

RBC Capital Markets downgraded Applied Therapeutics Inc (NASDAQ:APLT) stock to "sector perform" from "outperform” citing ...

As an investment banking associate at RBC Capital Markets, MBA graduate Emmanuel Fadahunsi is helping his clients drive ...

Strategists see falling inflation, resilient economic growth, and rising earnings driving further returns for the S&P 500 in ...

H&M is expected to continue expanding its presence, including a planned launch in Brazil next year. However, analysts remain ...

Analysts said that the figures were taken before Labour's 30 October Budget, which may yet have an impact on the housing ...

USA: Chicago-based private equity firm Wind Point Partners has completed a corporate carveout of locomotive services business ...

Extendicare Inc. has received a target price upgrade from RBC Capital Markets (Analyst Rank#3), which raised its price target to CAD 11 from CAD 9.50. The revision comes on the back of the company’s ...